Starting from (R)-N,N-dimethyl-1-ferrocenylethylamine, a diastereoselective ortho-lithiation procedure and a stereoconvergent intramolecular hydrophosphination gave access to P-chiral ferrocenephospholanes. These mono- or bidentate ligands were converted to the corresponding rhodium and iridium complexes, including a chiral version of Crabtree's catalyst, and tested in the asymmetric hydrogenation of functionalized and unfunctionalized olefins. A significant reactivity difference between the rhodium-1,5-cyclooctadiene and the rhodium-norbornadiene complex was observed during catalyst activation.
…P-chiral phospholanes can be readily prepared from (R)-N,N-dimethyl-1-ferrocenylethylamine by means of an ortho-lithiation procedure followed by a stereoconvergent hydrophosphination reaction. These mono-or bidentate ligands were converted to the corresponding Rh and Ir complexes, including a chiral version of Crabtree's catalyst, and tested in the asymmetric hydrogenation of olefins. For more details see the Full Paper by A. Pfaltz, B. Pugin et al. on page 12993 ff.
Inside CoverBjçrn Gschwend, Benoît Pugin*, Andreas Bertogg, and Andreas Pfaltz* Enantiomerically pure… …P-chiral phospholanes can be readily prepared from (R)-N,N-dimethyl-1-ferrocenylethylamine by means of an ortho-lithiation procedure followed by a stereoconvergent hydrophosphination reaction. These mono-or bidentate ligands were converted to the corresponding Rh and Ir complexes, including a chiral version of Crabtree's catalyst, and tested in the asymmetric hydrogenation of olefins. For more details see the Full Paper by A. Pfaltz, B. Pugin et al. on page 12993 ff.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.